CREATINE PHOSPHATE SODIUM FOR INJECTION

Creatine Phosphate Sodium for Injection is supplied by Hebei Tiancheng Pharmaceutical Co., Ltd. in a 1.0g specification (calculated as C4H8N3O5PNa2), administered by intravenous injection to protect the myocardium during cardiac surgery and to treat myocardial metabolic abnormalities arising from ischemia. The supplier's detailed clinical documentation covers its pharmacokinetics, typical dosing of 1.0g once or twice daily, and precautions, including caution around rapid infusion and use in patients with chronic renal insufficiency. Produced to the company's in-house standard, it is distributed across North America, Central/South America, Europe, Australasia, Asia, the Middle East, and Africa.